• Autologous stem cells as a promising therapeutic approach for augmentation of alveolar bone 

      Gjerde, Cecilie Gudveig (Doctoral thesis, 2020-08-28)
      The current gold standard for reconstructive bone surgery is based on autologous bone grafts. However, the risk of complications at both the donor and recipient sites is considerable. There is therefore a need to explore ...
    • Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial 

      Gjerde, Cecilie Gudveig; Mustafa, Kamal Babikeir Eln; Hellem, Sølve; Rojewski, Markus; Gjengedal, Harald; Yassin, Mohammed Ahmed Alamin Yousif; Feng, Xin; Skaale, Siren G; Berge, Trond Inge; Rosén, Annika; Shi, Xieqi; Ahmed, Aymen B; Gjertsen, Bjørn Tore; Schrezenmeier, Hubert; Layrolle, Pierre (Journal article; Peer reviewed, 2018)
      Background Autologous grafting, despite some disadvantages, is still considered the gold standard for reconstruction of maxillofacial bone defects. The aim of this study was to evaluate bone regeneration using bone ...
    • Patient experience following iliac crest alveolar bone gradfting av implant replacement 

      Gjerde, Cecilie Gudveig; Mustafa, Kamal Babikeir Eln; Gjengedal, Harald; Shanbhag, Siddharth; Neppelberg, Evelyn (Journal article; Peer reviewed, 2020-02-05)
      Background The objective of this study was to assess patient-reported outcomes such as satisfaction and quality of life after advanced alveolar bone augmentation with anterior iliac crest grafting and implant treatment ...
    • Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data 

      Rojewski, Markus Thomas; Lofti, Ramin; Gjerde, Cecilie Gudveig; Mustafa, Kamal Babikeir Eln; Veronesi, Elena; Ahmed, Aymen B; Wiesneth, Markus; Körper, Sixten; Sensebé, Luc; Layrolle, Pierre; Hellem, Sølve; Schrezenmeier, Hubert (Journal article; Peer reviewed, 2019)
      Background Many data are available on expansion protocols for mesenchymal stromal cells (MSCs) for both experimental settings and manufacturing for clinical trials. However, there is a lack of information on translation ...